21 results on '"Saijo, N."'
Search Results
2. Induction chemotherapy followed by gefitinib and concurrent thoracic radiotherapy for unresectable locally advanced adenocarcinoma of the lung: a multicenter feasibility study (JCOG 0402)
3. HSP70 CAUSES EGFR-TKIS RESISTANCE IN A MUTANT EGFR EXPRESSED NON-SMALL-CELL LUNG CANCER
4. miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo
5. Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines
6. RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED PHASE III STUDY OF WEEKLY ADMINISTRATION OF DARBEPOETIN ALFA IN ANEMIC PATIENTS WITH LUNG OR GYNECOLOGIC CANCER RECEIVING PLATINUM-CONTAINING CHEMOTHERAPY: 4A-S20-03
7. Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel
8. Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104)
9. A new statistical screening approach for finding pharmacokinetics-related genes in genome-wide studies
10. Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan
11. Genetic Variations and Haplotype Structures of the ABCB1 Gene in a Japanese Population: An Expanded Haplotype Block Covering the Distal Promoter Region, and Associated Ethnic Differences
12. Haplotype structures of the UGT1A gene complex in a Japanese population
13. Phase I–II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer
14. A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients
15. Randomized phase II study of cisplatin, irinotecan and etoposide combinations administered weekly or every 4 weeks for extensive small-cell lung cancer (JCOG9902-DI)
16. Anticancer Drug Discovery and Development Throughout the World
17. Relationship between objective responses in phase I trials and potential efficacy of non-specific cytotoxic investigational new drugs
18. Polymorphisms of metabolizing enzymes and transporter proteins involved in the clearance of anticancer agents
19. Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: Long-term follow-up results. Japan Clinical Oncology Group Protocol 8902
20. A phase II study of induction chemotherapy (CT) with CPT-11 and cisplatin followed by thoracic radiation (TRT) combined with weekly CPT-11 in patients with unresectable stage III non-small-cell lung cancer (NSCLC).
21. Bayesian Estimation for TDM of Anticancer Drugs: Evaluation of Different Population Methods: PIII-105
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.